Pulmonary Lymphomatoid Granulomatosis Inflammation in Dogs (Pulmonary Lymphomatoid Granulomatosis)

Open table of contents

When to visit the vet?

Non-urgent see a veterinarian within 2–3 days

?

If the condition worsens / symptoms persist, consult a veterinarian.

Download/Print

Definition

Pulmonary lymphomatoid granulomatosis is a rare, progressive disease in dogs characterized by the appearance of cancerous lymphatic cells in the lungs. These cells form nodules or granulomas that can impair normal lung function.

Das Wichtigste auf einen Blick

Pulmonary lymphomatoid granulomatosis in dogs is a condition involving the uncontrolled proliferation of lymphocytes, a type of white blood cell. These cells accumulate in the lungs and form granulomas. The exact causes are unclear, but it is suspected that a dysregulation of the immune system in combination with genetic factors plays a role. Viruses or other pathogens may also be involved, although none have been specifically identified. Certain dog breeds may be genetically more susceptible.

Typical symptoms include cough, respiratory distress, lethargy, and nasal discharge. Diagnosis is made through clinical examinations, X-rays, and often a lung biopsy to confirm the presence of cancerous cells. Immunosuppressive drugs and sometimes chemotherapy are often used for therapy to slow the disease. Supportive measures such as oxygen therapy and antibiotics may also be necessary.

The prognosis is guarded to poor, as the disease is progressive and can impair quality of life despite treatment. Early diagnosis and treatment can provide the best results, but the long-term prognosis is often poor. Since the causes are not fully understood, there are no specific preventive measures. However, regular veterinary check-ups and a healthy lifestyle can help promote the dog’s overall health and resilience.

Ursachen

Pulmonary lymphomatoid granulomatosis is a form of lymphoproliferative disease involving the uncontrolled proliferation of lymphocytes. Lymphocytes are a type of white blood cell that play an important role in the immune system. In this disease, it is believed that lymphocytes grow and accumulate uncontrollably, leading to the formation of granulomas.

The exact causes of the disease are not yet fully understood. However, it is thought that a dysregulation of the immune system in combination with genetic factors plays a role. Some researchers also suggest that viruses or other infectious agents could play a role in triggering this disease, although no specific pathogens have been identified so far.

Another possible factor could be a genetic predisposition in certain dog breeds. Some breeds seem to be more frequently affected, suggesting that certain genetic markers or mutations could increase susceptibility.

Symptoms

Symptoms of pulmonary lymphomatoid granulomatosis in dogs can vary but are often associated with breathing problems. The most common symptoms include cough, shortness of breath, and a general decrease in activity due to limited lung function.

Some dogs may also show signs of systemic illness, such as fever, weight loss, and loss of appetite. Since the disease affects the lungs, abnormal-sounding breath sounds or a change in respiratory rate may also be observed.

In advanced stages of the disease, there can be a significant impairment of quality of life as the lungs are no longer able to supply the body with sufficient oxygen. This can lead to a bluish tint to the mucous membranes and extreme weakness.

Diagnose

The diagnosis of pulmonary lymphomatoid granulomatosis usually begins with a thorough clinical examination and a review of the dog’s medical history. Suspicion often arises from characteristic symptoms and lung X-rays, which frequently show nodules or diffuse changes.

However, further tests are required to confirm the diagnosis. A computed tomography (CT) scan can provide more detailed information about the extent and distribution of the changes in the lungs. A definitive diagnosis usually requires a biopsy of the affected lung tissue to confirm the presence of cancerous lymphatic cells.

Additionally, blood tests and serological tests may be performed to rule out other possible causes of the symptoms and to assess the dog’s overall health. In some cases, a bronchoscopy may also be performed, using a camera to directly examine the airways and take tissue samples.

Therapie

Treatment for pulmonary lymphomatoid granulomatosis focuses on controlling symptoms and slowing the progression of the disease. In many cases, immunosuppressive drugs are used to reduce the activity of the immune system and slow the growth of lymphatic cells.

Chemotherapy approaches may also be considered, especially if the disease is aggressive or does not respond to conventional treatments. The choice of medication and the duration of treatment depend on the severity of the disease and the dog’s response to therapy.

In addition to medication, supportive therapy may be required to improve the dog’s quality of life. This may include oxygen therapy, the administration of antibiotics to prevent secondary infections, and nutritional support.

Prognose und Nachsorge

The prognosis for dogs with pulmonary lymphomatoid granulomatosis is generally guarded to poor. The disease is progressive and can lead to a significant impairment of quality of life despite treatment.

Survival time can vary depending on how early the disease is diagnosed and how well the dog responds to treatment. Some dogs may respond well to therapy and remain stable for a period of time, while in others, the disease may progress rapidly.

In many cases, however, the long-term prognosis is poor, and treatment aims primarily at relieving symptoms and improving quality of life rather than achieving a cure.

Prävention

Since the exact causes of pulmonary lymphomatoid granulomatosis are not fully understood, there are no specific preventive measures to avoid the disease. However, early detection and diagnosis are crucial to achieving the best treatment outcomes.

Regular veterinary check-ups and close observation of symptoms can help detect the disease at an early stage and start treatment in time. Dog owners should consult a veterinarian immediately if they notice signs of respiratory distress or other unusual symptoms.

A healthy lifestyle, including a balanced diet and appropriate exercise, can contribute to the dog’s general health and resilience, even if this may not directly prevent the development of the disease.

Frequently Asked Questions (FAQs)

1. What is pulmonary lymphomatoid granulomatosis?
Pulmonary lymphomatoid granulomatosis (PLG) is a rare, cancer-like disease in which atypical lymphoid cells and granulomas develop in the lungs. It is now considered a lymphoproliferative disorder occupying an intermediate position between an inflammatory granulomatosis and a true lymphoma.
2. Which dogs are affected?
The disease occurs in dogs of any age but is more common in middle-aged animals. There is no clear breed predisposition, with a slight overrepresentation of medium-sized and large breeds. A possible link with chronic inflammation or specific infections has been discussed.
3. What symptoms occur?
Typical signs are chronic cough, dyspnea, exercise intolerance, weight loss, anorexia and fever. Symptoms usually develop over weeks. In advanced disease, extrathoracic involvement of the kidneys, skin or central nervous system is also possible.
4. How is the diagnosis made?
Radiographs and CT typically show nodular, sometimes confluent pulmonary lesions, often with lymphadenopathy. Definitive diagnosis requires biopsy, usually obtained transthoracic, bronchoscopically or surgically. Histology and immunohistochemistry (predominantly T-cell-rich infiltrates) are decisive.
5. How is the disease treated?
Chemotherapy is the treatment of choice, often with protocols also used for lymphoma (such as CHOP). Corticosteroids complement treatment. For solitary lesions, surgical removal can be considered, but the disease is usually multifocal.
6. Is PLG a true lymphoma?
PLG is currently classified as an angioimmunoproliferative process with lymphomatoid features. It shares characteristics with both granulomas and lymphomas. Treatment follows lymphoma protocols, which provide the best response rates.
7. What prognosis can be expected?
Without treatment, the disease progresses rapidly and is fatal within a few months. With chemotherapy, many dogs achieve remission with median survival times of 6 to 12 months, and some considerably longer.
8. Can PLG progress to a classical lymphoma?
Progression to a more aggressive T-cell lymphoma has been described. For this reason, structured follow-up with imaging and clinical assessment is important to detect changes early and adapt therapy.
9. What side effects does chemotherapy have?
Modern veterinary chemotherapy protocols are considerably gentler than human regimens. Possible side effects include mild gastrointestinal symptoms, transient leukopenia and rarely infections. Quality of life remains good in most dogs during treatment.
10. How does PLG differ from bacterial pneumonia?
Bacterial pneumonia responds to antibiotics and usually shows diffuse inflammatory changes. PLG produces nodular structures, does not respond to antibiotics and progresses without specific therapy. Histology is ultimately decisive for the correct diagnosis.